-
A Phase 2b/3 Trial of Ibudilast for ALS Was Launched by MediciNova
ALS News Today’s Director of Multichannel Content, Michael Morale, discusses a phase 2b/3 trial of Ibudilast for ALS, which was launched by MediciNova.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.